Entrada Therapeutics Inc. logo

Entrada Therapeutics Inc.

TRDA | NASDAQ
Chart Builder DCF Calculator
$6.83
+$0.19 (+2.86%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-143.75M 65.63M -6.69M -94.62M -51.16M -26.52M
Depreciation & Amortization
4.1M 3.77M 2.84M 1.9M 1.12M 326K
Stock-Based Compensation
19.61M 17.92M 13.11M 9.9M 2.53M 325K
Other Working Capital
-5.5M -122.04M 139.12M -16.4M -2.71M -349K
Other Non-Cash Items
-3.67M -10.02M -5.78M 151K 74K 20K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-4.8M -118.85M 136.32M -11.11M -3.42M 282K
Operating Cash Flow
-128.51M -41.56M 139.8M -93.79M -50.86M -25.57M
Capital Expenditures
-1.04M -3.16M -5.61M -2.89M -4.58M -2.32M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-141.61M -437.72M -407.21M -221.98M n/a n/a
Sales Maturities Of Investments
259.46M 413.08M 274.43M 76.21M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
116.81M -27.8M -138.4M -148.65M -4.58M -2.32M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 3.36M 1.63M n/a 939K 247K
Financial Cash Flow
887K 102.96M 21.04M 479K 307.46M 50.09M
Net Cash Flow
-10.82M 33.61M 22.45M -245.91M 252.02M 22.2M
Free Cash Flow
-129.55M -44.72M 134.19M -96.67M -55.44M -27.89M
Adj. Free Cash Flow
-149.16M -62.63M 121.08M -106.57M -57.97M -28.21M
Maintenance CapEx
-1.04M n/a n/a -1.9M -1.12M -326K
Growth CapEx
n/a -3.16M -5.61M -992K -3.46M -1.99M
Owner Earnings
-129.55M -41.56M 139.8M -95.68M -51.98M -25.9M

© 2026 bestshares.com. All rights reserved.